diet doctors

More Obesity Drugs in the Pipeline – Boehringer Ingelheim

August 20, 2023 Boehringer Ingelheim could soon stake a claim in the lucrative obesity treatment market after the pharma company said it has advanced a candidate into three Phase III trials following promising data. Servodutide, the company’s glucagon/glucagon-like peptide 1 (GLP-1) receptor dual agonist co-developed with Zeland Pharma, demonstrated up to 19% weight loss after …

More Obesity Drugs in the Pipeline – Boehringer Ingelheim Read More »

Medifast Reports Q2 Results

News / By John LaRosa

Aug. 8, 2023 Second quarter 2023 revenue decreased 34.7% to $296.2 million from $453.3 million for the second quarter of 2022, primarily driven by a decrease in the number of active earning OPTAVIA Coaches and the decline in the productivity per active earning OPTAVIA Coach. The average revenue per active earning OPTAVIA Coach was $5,578, compared to $6,667 for the second quarter last year, a …

Medifast Reports Q2 Results Read More »

Weight Watchers Reports 2nd Quarter 2023 Results

News / By John LaRosa

Aug. 5, 2023 WW reported its second quarter results yesterday. End of Period Subscribers of 4.1 million Revenues of $226.8 million Operating Income of $26.3 million; excluding the net impact of restructuring charges and acquisition transaction costs, adjusted operating income of $33.9 million Full Year Fiscal 2023 Guidance: Revenues are expected to be in the …

Weight Watchers Reports 2nd Quarter 2023 Results Read More »

Semaglutide Gold Rush Is On, Compounding Pharmacies

News, Uncategorized / By John LaRosa

June 5, 2023 There is no doubt that the new obesity drugs (Wegovy, Ozempic) are hot and in high demand, but there is a disturbing new trend developing. Since the brand name drugs often cost $1,000 to $1,300 per month and are not covered by insurance, people are looking for cheaper alternatives. That’s where compounding …

Semaglutide Gold Rush Is On, Compounding Pharmacies Read More »

Noom Is Testing Weight Loss Drugs

News, Uncategorized / By John LaRosa

April 19, 2023 We obtained some information regarding Noom’s participation in the medical weight loss arena. “…Noom Clinical is offered to adults (18+) that are over BMI 30 or, BMI 27 and above with obesity-related conditions. Individual eligibility for specific options is determined by our trained clinicians and overseen by our Chief of Medicine. With …

Noom Is Testing Weight Loss Drugs Read More »

Weight Loss Market Recovers to $75 Billion – New Marketdata Report

News, Uncategorized / By John LaRosa

March 20, 2023 Marketdata LLC, Tampa, FL, has just released it 17th Edition of its best-selling market research report: “The U.S. Weight Loss & Diet Control Market”. At 427 pages, with 160 Tables & Charts and 34 in-depth diet company competitor profiles, this is the most comprehensive analysis anywhere of the market. Some findings… The …

Weight Loss Market Recovers to $75 Billion – New Marketdata Report Read More »

WW Enters Medical Wt. Loss Mkt, 2022 Results

News / By John LaRosa

March 7, 2023 Weight Watchers has entered into a definitive agreement to acquire Weekend Health, Inc., d/b/a Sequence, a subscription telehealth platform offering access to healthcare providers specializing in chronic weight management via the use of medications. Sequence seamlessly integrates the patient and clinician experience for ongoing, clinical care and medication management while providing high-touch support …

WW Enters Medical Wt. Loss Mkt, 2022 Results Read More »

“Ozempic Face” Side Effect

News / By John LaRosa

January 27, 2023 Ozempic is a medication that’s designed to help manage insulin levels in people with type 2 diabetes. However, it’s recently gotten attention after some people spoke out on social media about using the drug for weight loss. Ozempic, which is a brand name for semaglutide, is currently on the Food and Drug Administration’s list of …

“Ozempic Face” Side Effect Read More »

Found Finds $ For New Weight Loss Venture

News, Uncategorized / By John LaRosa

Sept. 3, 2022 Found Health is a new weight loss company that claims to offer a science-backed solution for personalized, lasting weight care that addresses the missing link in the existing weight loss market: biology. Found is a direct-to-consumer healthcare company with a focus on supporting your weight loss journey holistically, based on the science of …

Found Finds $ For New Weight Loss Venture Read More »

Semaglutide a Game Changer Drug?

News, Uncategorized / By John LaRosa

Dec. 30, 2021 2021 was a historic year for obesity treatment. In June, the Food and Drug Administration approved the weight loss drug semaglutide, which some experts described as a “game changer”. The medication, initially developed to treat Type 2 diabetes, was the first drug treatment to be approved by the FDA for weight management since 2014. Wegovy, …

Semaglutide a Game Changer Drug? Read More »

(813) 971-8080